Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
marizomib (NPI-0052)
i
Other names:
NPI-0052
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
BMS, Triphase Accelerator Corporation
Drug class:
Proteasome inhibitor
Related drugs:
‹
bortezomib (90)
ixazomib (31)
carfilzomib (18)
MG132 (1)
AVA3996 (0)
CEP-18770 (0)
ONX 0912 (0)
bortezomib (90)
ixazomib (31)
carfilzomib (18)
MG132 (1)
AVA3996 (0)
CEP-18770 (0)
ONX 0912 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
IDH2 mutation
Glioma
IDH2 mutation
Glioma
NPI-0052
Sensitive: D – Preclinical
NPI-0052
Sensitive
:
D
NPI-0052
Sensitive: D – Preclinical
NPI-0052
Sensitive
:
D
IDH1 mutation
Glioma
IDH1 mutation
Glioma
NPI-0052
Sensitive: D – Preclinical
NPI-0052
Sensitive
:
D
NPI-0052
Sensitive: D – Preclinical
NPI-0052
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login